William Tanner

Stock Analyst at Cantor Fitzgerald

(0.80)
# 4,039
Out of 5,120 analysts
5
Total ratings
20%
Success rate
-2.35%
Average return

Stocks Rated by William Tanner

Prothena Corporation
Mar 4, 2019
Assumes: Overweight
Price Target: n/a
Current: $8.91
Upside: -
TherapeuticsMD
Aug 14, 2018
Maintains: Overweight
Price Target: $1,300$1,350
Current: $2.26
Upside: +59,634.51%
Xencor
Nov 29, 2017
Initiates: Overweight
Price Target: $33
Current: $12.11
Upside: +172.50%